Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03283982 · ClinicalTrials.gov registry record · NA

Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT03283982 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03283982, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The investigators aim to conduct a registry-based, randomized controlled trial to investigate if the robotic platform for minimally invasive ventral hernia repair with intraperitoneal onlay mesh (IPOM), when compared to the laparoscopic platform, will influence on early postoperative pain scores, wound morbidity (surgical site infections, surgical site occurrences and surgical site occurrences requiring procedural intervention), ventral hernia recurrence rate and abdominal wall-specific quality of life.

Interventions

  • DEVICE Robotic Ventral Hernia Repair with IPOM
  • DEVICE Laparoscopic Ventral Hernia Repair with IPOM

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2017-09-11
Est. Completion 2021-01-31
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03283982

The ClinicalTrials.gov registry entry for NCT03283982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Robotic Ventral Hernia Repair with IPOM is the first listed.

NCT03283982 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03283982 about?

NCT03283982 is a clinical study titled "Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM". The investigators aim to conduct a registry-based, randomized controlled trial to investigate if the robotic platform for minimally invasive ventral hernia repair with intraperitoneal onlay mesh (IPOM), when compared to the laparoscopic platform, will influence on early postoperative pain scores, wo...

What is the current status of trial NCT03283982?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2017-09-11. Estimated completion is 2021-01-31.

What interventions are being tested in trial NCT03283982?

The interventions under investigation include: Robotic Ventral Hernia Repair with IPOM (DEVICE), Laparoscopic Ventral Hernia Repair with IPOM (DEVICE).

Who is sponsoring clinical trial NCT03283982?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.